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Multiple human diseases are associated with a
liquid-to-solid phase transition resulting in the
formation of amyloid fibers or protein aggregates.
Here, we present an alternative mechanism for
cellular toxicity based on a concentration-dependent
liquid-liquid demixing. Analyzing proteins that are
toxic when their concentration is increased in yeast
reveals that they share physicochemical properties
with proteins that participate in physiological liquid-
liquid demixing in the cell. Increasing the concen-
tration of one of these proteins indeed results in the
formation of cytoplasmic foci with liquid properties.
Demixing occurs at the onset of toxicity and titrates
proteins and mRNAs from the cytoplasm. Focus
formation is reversible, and resumption of growth
occurs as the foci dissolve as protein concentra-
tion falls. Preventing demixing abolishes the dosage
sensitivity of the protein. We propose that triggering
inappropriate liquid phase separation may be an
important cause of dosage sensitivity and a determi-
nant of human disease.
INTRODUCTION
A subset of the proteins encoded in any genome is toxic when
their expression level is increased (Gelperin et al., 2005; Sopko
et al., 2006). Even small increases in dosage can be detrimental
(Tomala et al., 2014) with dosage sensitivity causing a large num-
ber of human diseases, ranging from developmental defects to
psychiatric disorders (Girirajan et al., 2011; Veitia and Birchler,
2010).
Whether an individual protein is toxic or not when over-
expressed may depend both on its specific functions and on
its intrinsic physicochemical properties. For example, imbal-
ance in regulatory networks or in the assembly of protein222 Cell Reports 16, 222–231, June 28, 2016 ª 2016 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://complexes (Papp et al., 2003; Veitia, 2003), aggregation
(Geiler-Samerotte et al., 2011; Tartaglia et al., 2007), and
mass-action driven promiscuous molecular interactions (Va-
vouri et al., 2009) have all been suggested to cause dosage
sensitivity. However, the precise molecular mechanism by
which each individual protein becomes harmful when overex-
pressed is normally unknown.
The cytoplasm and nuclei of cells are crowded environments
containing very high concentrations of macromolecules. One
principle that is becoming increasingly appreciated as a means
for how cells organize and compartmentalize their contents is
liquid-liquid phase separation (Brangwynne et al., 2009; Hyman
et al., 2014; Jain et al., 2016). Liquid demixing creates non-mem-
brane bound organelles that rapidly exchange molecules with
the surrounding cytoplasm and increases the concentration of
particular macromolecules within the separated phase. Exam-
ples include germ granules (Brangwynne et al., 2009), the nucle-
olus (Brangwynne et al., 2011; Weber and Brangwynne, 2015),
and other ribonucleoprotein (RNP) assemblies (Lin et al., 2015;
Mitchell et al., 2013). Although the precise molecular details
about how liquid-liquid demixing is initiated are still unknown,
the process is tightly controlled (Wippich et al., 2013).
Several proteins involved in physiological liquid-liquid demix-
ing are prone to form protein aggregates or amyloids when
they carry disease-causing mutations (Hyman et al., 2014; Kim
et al., 2013; Patel et al., 2015) and indeed these mutations can
promote a transition from a liquid droplet to a solid phase in vitro
(Patel et al., 2015). This has led to the proposal that a liquid-to-
solid phase transition is a mechanism of cellular toxicity (Patel
et al., 2015).
Here, based on a proteome-wide analysis in yeast, we report
that dosage-sensitive proteins share characteristics with pro-
teins known to undergo physiological liquid-liquid demixing.
Overexpressing one of these proteins revealed that it is indeed
the induction of a liquid-liquid phase separation that correlates
with toxicity. The condensation of this concentration-dependent
liquid phase requires the RNA-binding domains of the protein
and decondensation occurs as protein concentrations drop,
reversing the growth impairment. Genetically preventing thecreativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Dosage-Sensitive Proteins Have
an Intrinsic Propensity for Liquid-Liquid
Phase Separation
(A) Ability of physico-chemical features to
discriminate dosage-sensitive and granule form-
ing sets from the rest of the yeast proteome. The
area under the receiver operating characteristic
curve (AUC) is used to measure performances
of individual properties and combinations of
them. Performances of the catGRANULE algo-
rithm (Experimental Procedures) are highlighted
with a green square.
(B) Distribution of granule propensities calculated
with catGRANULE (Experimental Procedures) for
annotated granule forming proteins (n = 120),
dosage-sensitive proteins as reported in Sopko
et al. (2006) (n = 770) and Makanae et al. (2013)
(n = 777) and the rest of the S. cerevisiae proteome
(n = 3,726). Boxes represent the range between
the 25th and 75th percentile. Grey dashed line in-
dicates the propensity value for Mip6p.
(C) Performance of the model on ‘‘granule form-
ing’’ genes (AUC: 0.86) and on the independent
test set ‘‘granule related’’ genes (AUC: 0.72). See
also Table S1 for full table of ORFs.
See also Figure S1.liquid phase separation prevents the dosage sensitivity of this
protein. This establishes that inappropriate liquid-liquid demix-
ing can be a cause of concentration-dependent dosage sensi-
tivity. Thus, both liquid-to-solid and liquid-to-liquid phase transi-
tions can underlie cellular toxicity and may contribute to human
genetic disease.
RESULTS
Dosage-Sensitive Proteins Have an Intrinsic Propensity
for Liquid-Liquid Phase Separation
To better understand concentration-dependent cellular toxicity,
we analyzed the properties of dosage-sensitive genes identified
in two genome-wide screens in yeast (Makanae et al., 2013;
Sopko et al., 2006). In addition to the previously reported high
intrinsic protein disorder content (Vavouri et al., 2009), we found
that dosage-sensitive proteins have a strong propensity to bind
nucleic acids (Figure 1A). Recent studies have highlighted the
potential for disordered and low complexity sequences to
bind RNA (Castello et al., 2012), so we reasoned that these
two features might be related. Consistent with this, we found
that dosage-sensitive proteins are enriched for nucleic acid
binding-propensity even after removing all known transcription
factors (Figure S1A).CeStructural disorder and nucleic acid-
binding are properties of proteins that
assemble into RNP foci. The formation
of these foci occurs by liquid-liquid phase
separation (Brangwynne et al., 2009; Hy-
man et al., 2014;Weber andBrangwynne,
2012) and it is normally a highly regulated
process (Malinovska et al., 2013). Basedon the enrichment of the same properties among dosage-sensi-
tive proteins, we hypothesized that some dosage-sensitive pro-
teins might impair cellular function by triggering an inappropriate
liquid phase separation as their concentration increases.
A Computational Method for Predicting Liquid Demixing
also Distinguishes Dosage-Sensitive Genes
To evaluate the potential of proteins to participate in phase sep-
aration, we trained an algorithm to distinguish between proteins
known to localize to foci within the cytoplasm or nucleus and the
rest of the proteome (Experimental Procedures; Table S1, the
catGRANULE algorithm) (Mitchell et al., 2013). Our approach
predicts whether a protein takes part in foci-formation by consid-
ering the contributions of structural disorder and nucleic acid
binding propensities and, to a lesser degree, sequence length
and arginine, glycine, and phenylalanine content (R, G, F), which
are enriched in granule-forming proteins (Kato et al., 2012;
Thandapani et al., 2013) (Figure 1A; Experimental Procedures).
The algorithm showed good performance with an area under
the receiver operating characteristic curve, an area under the
curve (AUC), of 0.86 (Figures 1A and 1C, on an independent
test set the AUC is 0.72; Experimental Procedures).
Applying the approach to the entire yeast proteome revealed
that dosage-sensitive proteins (Makanae et al., 2013; Sopkoll Reports 16, 222–231, June 28, 2016 223
Figure 2. Mip6p Changes Localization when Overexpressed
(A) Cellular localization ofMip6-GFP at different levels of overexpression. Co-localizationwith Edc3p is observedwhenMip6 is expressed from theGal1 promoter.
(B) Growth rates of strains expressing Mip6 under the control of different promoters, error bars represent SDs of three independent replicates.
(C) Number of foci per cell as counted by monitoring GFP-tagged endogenous levels of Dhh1, Lsm1, and Mip6 in BY4741 (left), or counted in the same strains as
in A); 50–100 cells for each condition were counted.
(D) Western blot where an antibody against HA was used to detect different amounts of Mip6p upon expression under weak (GalS), medium (GalL), and strong
(Gal1) promoters.
See also Figure S2.et al., 2006) have a propensity to assemble into foci that is inter-
mediate between known granule-associated proteins and the
rest of the proteome (Figure 1B). In addition, known granule-
associated proteins are enriched among dosage-sensitive pro-
teins (Figure S1B). Indeed, our algorithm is a better predictor of
dosage sensitivity than intrinsic disorder content, nucleic acid
binding propensity, or a linear combination of the two (Figure 1A).224 Cell Reports 16, 222–231, June 28, 2016The Dosage-Sensitive Protein Mip6p Changes
Localization when Overexpressed
Using three inducible promoters of increasing strength, we
overexpressed ten dosage-sensitive proteins with intermediate
to high granule propensity and identified one protein, Mip6p,
whose sub-cellular localization was altered when overexpressed
(Table S2) (Figures 2A and 2D). Mip6p is a lowly expressed
(Wang et al., 2015) protein containing four RNA recognition motif
(RRM) domains and two short low-complexity regions. It has a
granule-propensity that deviates above 1 SD from the proteome
mean (granule propensity = 1.05). Moderate overexpression of
Mip6p is not toxic (Figure 2B). However, strong overexpression
inhibits growth (Figure 2B). When moderately overexpressed,
Mip6p has a mostly diffuse cytoplasmic localization (Figure 2A),
while at concentrations that impair growth, the protein re-local-
izes to cytoplasmic foci (Figures 2A and 2B).
Mip6p Foci Associate with P-Body Components
To characterize the assemblies formed by Mip6p, we co-ex-
pressed it with markers for various cellular compartments and
structures and found that the Mip6p foci partially co-localize
with Edc3p (Figure 2A). Edc3p is a known component of cyto-
plasmic ribonucleoprotein granules referred to as P-bodies
(Kedersha et al., 2005) (Figure 2A). The Mip6p foci also partially
co-localize with another P-body component, Dcp1p (Figure S2).
P-bodies constitute sites of mRNA storage and turnover and, in
wild-type cells, their formation can be stimulated in response to
osmotic stress (Decker and Parker, 2012). However, P-bodies
induced by osmotic stress do not contain Mip6p when it is ex-
pressed at endogenous levels (Figure 2C). Rather, Mip6p only
co-localizes with P-body components when overexpressed
(Figure 2C) and in both the presence and absence of osmotic
stress (Figure 2C). Thus, Mip6p both induces the formation of
P-body-like assemblies and partially localizes to these foci
when overexpressed.
Mip6p Foci Have Liquid Properties
Next, we further characterized the biophysical properties of the
Mip6p foci. We found that overexpression of Mip6p did not result
in the formation of large insoluble protein aggregates similar
to those of a poly-glutamine peptide (103Q) (Figure 3A), which
we overexpressed with a GFP tag. The Mip6p foci also did not
contain the chaperone Hsp104p (Figure 3A), a marker of intra-
cellular aggregation compartments in yeast (Kaganovich et al.,
2008). Indeed, the conformational antibody OC that specifically
binds to fibrillar species (Kayed et al., 2007), showed no binding
to whole cell protein extracts from Mip6p overexpressing cells
but showed preferential interaction with 103Q aggregates (Fig-
ure 3D). The Mip6p foci, unlike 103Q aggregates, showed rapid
fluorescence recovery after photo-bleaching (Figures 3B and
3C). We also observed that the Mip6p foci disassemble when
cells are treated with the aliphatic alcohol 1,6-hexanediol, which
is able to disrupt weak hydrophobic interactions (Kroschwald
et al., 2015; Patel et al., 2007). This effect is reversible, as
Mip6p foci reassemble within 30 min after removal of the alcohol
(Figure S3A). Moreover, we found that the Mip6p foci are often
inherited by daughter cells (Figure S3B), further distinguishing
them from misfolded protein compartments that are asymmetri-
cally inherited by mother cells (Ogrodnik et al., 2014). Occasion-
ally, we observed fusion of two foci in the cytoplasm, as well as
splitting of one focus into two (Figure S3C). Taken together, our
results show that the Mip6p foci have a dynamic structure and
liquid-like properties, rapidly exchanging molecules with the
free cytoplasmic protein pool. This set of properties recapitu-
lates the behavior of a known liquid phase-separating proteinfrom Caenorhabditis elegans, PGL-3 (Brangwynne et al., 2009),
when we overexpressed it in yeast (Figure S4).
Focus Formation Is Reversible with Growth Resuming
upon Dissolution
Using single-cell imaging, we investigated the behavior of Mip6p
assemblies when the Mip6p protein concentration was reduced
in live cells. We expressed Mip6p from an inducible promoter
until foci formed and then changed the media to repress further
protein production (Experimental Procedures). Whereas the
cytoplasmic foci formed by 103Q remained stable, the assem-
blies formed by Mip6p and PGL-3 dissolved with the redistri-
bution of the fluorescent signal across the whole cytoplasm
(Movies S1, S2, and S3). The maintenance of the Mip6p foci
therefore requires a high protein concentration; as the concen-
tration drops below a critical level, the foci dissolve.
We used automated microscopy to follow the growth dy-
namics of individual micro-colonies following the inhibition of
Mip6p production. We found a strong correlation between
the dissolution of foci and the resumption of rapid colony
growth, consistent with Mip6p foci being the cause of impaired
growth (Figure 4A). When the foci disappear, cells resume
growth. These findings are in line with what we observe for
PGL-3 overexpressing cells in the same single colony assay
(Figure S4A). By means of fluorescence-activated cell sorting
(FACS) we could also separate cells with higher fluorescence in-
tensity and containing cytoplasmic assemblies from cells with
lower protein concentrations and mostly diffuse fluorescence.
Following sorting, we allowed the two populations to grow in a
micro-colony growth assay and confirmed higher growth rates
for cells with diffuse Mip6p compared to cells with Mip6p foci
(Figure 4B).
Focus Formation and Toxicity Require RNA Binding
Domains
To identify the regions of Mip6p required for focus formation,
we overexpressed a series of protein fragments and moni-
tored their subcellular localization by fluorescence microscopy.
Mip6p contains an N-terminal disordered region (aa 1–32), two
short low complexity regions (aa 82–93 and aa 525–546),
and four RRMs (aa 112–185, aa 200–270, aa 314–385, and aa
403–476) (Figure 5A). Whereas overexpression of the two N-ter-
minal fragments (aa 1–112 and aa 1–190) or the C terminus (aa
476–660) did not result in the formation of foci, overexpression
of other truncated variants did (Figure S5). The protein fragments
leading to formation of cytoplasmic assemblies vary in length,
but all contain at least two RRMs (Figure S5). The N-terminal
disordered region and the low complexity regions are not
required for triggering focus assembly, but two RRMs alone
are sufficient, suggesting that focus formation requires Mip6p
to interact with RNA. Using our computational method to score
each fragment on the basis of its intrinsic physicochemical prop-
erties (Granule Strength, Equation 3), we find that the variants
with a value >0 are associated with foci formation (Figures 5B
and S5).
Next, we tested whether overexpression of the different
protein fragments affected growth. Only overexpression of the
fragments that formed cytoplasmic assemblies caused a growthCell Reports 16, 222–231, June 28, 2016 225
Figure 3. Mip6p Foci Have Liquid Properties
(A) Localization of the chaperone Hsp104 in cells showing either 103Q assemblies or Mip6p cytoplasmic foci.
(B) An example of fluorescence recovery after photobleaching for Mip6p foci.
(C) Average trends of fluorescence recovery after photo-bleaching for 103Q (left) and Mip6p (right) cytoplasmic assemblies.
(D) Dot blot assay showing differential binding of the OC conformational antibody to protein extracts from wild-type (WT) cells or cells expressing 103Q or Mip6p.
See also Figures S3 and S4.defect (Figure 5B) with growth rates anti-correlated with the
score assigned to the sequence by our computational model
(Figure 5B). We conclude that both foci formation and cellular
toxicity are primarily driven by the RNA-binding domains of
Mip6p.
Foci Contain RNA
The presence of RNA in the Mip6p foci was confirmed by their
co-localization with the nucleic acid dye Syto14 (Schisa et al.,
2001) (Figure S6A). To further understand the role of RNA in
the formation of the Mip6p foci, we treated cells overexpressing
Mip6p with cycloheximide, an inhibitor of translation elonga-
tion that traps mRNAs on polysomes and depletes them from
the cytoplasm (Teixeira et al., 2005). Consistent with a role for
mRNA in their stability, cycloheximide treatment dissolved foci
formed upon Mip6p overexpression (Figure S6B).226 Cell Reports 16, 222–231, June 28, 2016Mip6p Foci Are Associated with Translation Inhibition
How does Mip6p focus formation trigger toxicity? Physiological
P-bodies contain protein translation factors and are associated
with translation slow down (Parker and Sheth, 2007; Walters
et al., 2015). A simple hypothesis is therefore that Mip6p foci,
by titrating proteins and mRNAs from the cytoplasm, impair
the translation capacity of the cell. Consistent with this, we found
that global translation rates were severely reduced in cells over-
expressing Mip6p (Figure 6).
Preventing Liquid-Liquid Demixing Prevents Dosage
Sensitivity
The correlations between formation of foci and growth impair-
ment when Mip6p (Figure 2B) or its fragments (Figure 5B) are
overexpressed and direct comparison across micro-colonies
(Figure 4A) strongly suggest that foci formation is required
Figure 4. Growth Resumes after Dissolution of Foci
(A) Average growth rates quantified by automated micro-colony growth assay before dissolution of cytoplasmic Mip6p assemblies (dark green), after their
dissolution (light green), or for the colonies in which dissolution was not observed (gray). Boxes represent the 95% confidence interval (CI), while points
correspond to the growth rate measurements of all individual micro-colonies.
(B) Average growth rate during re-growth after FACS sorting for cells displaying cytoplasmic assemblies (blue) and cells displaying soluble fluorescence (red).
See also Figures S3 and S4 and Movies S1, S2, and S3.for growth impairment. To provide an additional test of this, we
reasoned that deletion of genes encoding P-body components
might prevent the formation of Mip6p foci. Deleting both edc3
and pat1 has been previously shown to impair P-body formation
(Lavut and Raveh, 2012), and indeed deletion of these two genes
abolished the formation of Mip6p foci (Figures 7A and S6C).
Edc3p and Pat1p are therefore required for the formation of the
foci when Mip6p is overexpressed, allowing us to test whether
focus formation is required for toxicity. Deletion of edc3 and
pat1 suppresses the growth impairment caused by overexpres-
sion of Mip6p (Figure 7B).
DISCUSSION
We have shown here that dosage-sensitive proteins in yeast
share physicochemical properties with proteins known to un-
dergo liquid phase separation and that, for at least one protein,
liquid-liquid demixing is associated with the growth impair-
ment when the protein is overexpressed. The physicochemical
properties associated with liquid phase separation are more
common in the proteins of eukaryotes (Figure S7A). For example,
whereas disordered regions make up 5% of the proteome in
bacteria, they compose >30% in humans (van der Lee et al.,
2014). Thus, many human proteins may have the potential to
induce liquid phase separations when their concentration is
increased. We propose therefore that the mechanism of dosage
sensitivity that we have demonstrated here for Mip6p—a con-
centration-dependent triggering of liquid phase separation—
may also occur in human disease.
Most recent studies have focused on liquid-to-solid phase
changes as a mechanism of cellular pathology (Jain et al.,
2016; Kato et al., 2012; Kim et al., 2013; Patel et al., 2015).
For example, the protein FUS participates in physiologicalliquid-liquid phase separation in vivo and both disease muta-
tions and increased concentration can accelerate the conver-
sion of FUS liquid compartments to solid aggregates in vitro
(Patel et al., 2015). Indeed, given that both liquid-to-liquid and
liquid-to-solid phase transitions are intrinsically concentra-
tion-dependent (Lee et al., 2013; Weber and Brangwynne,
2012) it is reasonable to propose that both types of phase
transition can cause dosage sensitivity, cellular toxicity, and
disease. Thus, whereas for some proteins overexpression or
mutation will promote an inappropriate liquid-to-solid phase
transition, for other proteins an inappropriate liquid-to-liquid
transition may be the cause of concentration- or mutation-
dependent pathology.
Finally, we note that Mip6p foci—that have a substantial influ-
ence on growth rate—are often inherited by both the mother
and daughter cells after cell division. Two important remaining
questions are therefore whether and how such assemblies could
act as epigenetic elements of inheritance in an isogenic
population.EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Overexpression was performed using promoter swapping in a derivative
of Saccharomyces cerevisiae S288C (MATa ura3-52 his3D200 leu2 lys2-
801 ade2-101 trp1D63), or S288C BY4741 (MATa his3D1 leu2D0 met15D0
ura3D0) in the case of the experiments on the double deletion strain (edc3D,
pat1D) reported in Figure 7. The Gal-1, Gal-L, and Gal-S promoters were
amplified via tool-box PCR amplification (Janke et al., 2004). For localization
and immunochemistry analysis, the same genes were tagged with either
GFP or hemagglutinin (HA) bymeans of the samemethod. Amplified fragments
were integrated via a standard lithium acetate transformation protocol and the
correct insertion of the promoter was verified by PCR on extracted genomic
DNA. 103Q and PGL-3 were expressed via cloning into p426-Gal1 (Addgene).Cell Reports 16, 222–231, June 28, 2016 227
Figure 5. Protein Domains Able to Form
Foci Impair Growth when Overexpressed
(A) A scheme of MIP6p sequence as annotated
by ELM (Dinkel et al., 2016) (yellow, disordered
region; purple, RNA recognition motifs; red, low
complexity sequences.
(B) Growth rate (black) of strains overexpressing
Mip6p truncated variants with corresponding
granule strength (green). Error bars represent SD
of three independent replicates. Granule strength
is calculated on fragments extracted from the
Mip6p profile (Figure S7B) as explained in the
Experimental Procedures.
See also Figure S5.For the characterization of Mip6p deletion variants, fragments of the coding
sequence were amplified and cloned into p426-Gal1 vector.
Fitness Assays
Strains were grown to saturation in either Synthetic Complete or YPDA (Raffi-
nose 2%) medium and diluted to 0.15 optical density (OD) 600 nm for a sec-
ond growth of 6–8 hr in the same medium. At this stage, strains were diluted
again at 0.15 OD 600 nm in Raffinose or Galactose medium to assess
growth in non-inducing versus inducing conditions. Growth was monitored
bymeasuring OD 600 nm in a 96-well plate incubated at 30C inside the Infinite
M200 microplate reader (Tecan). Growth curves were fitted and growth rate
was calculated implementing the approach described by Hall et al. (2014).
Localization Screen
Strains were grown in inducing conditions until exponential phase and imaged
under 1003 magnification on a DMRE fluorescence microscope with PRIOR
Lumen 200 light (Leica).
Flow Cytometry
Cells were analyzed at a medium flow rate in a FACSaria flow cytometer. The
signal coming from cell aggregates was eliminated on the basis of the forward
scatter area and height. Populations were separated on the basis of fluores-
cence intensity. We collected 106 events for each sample. Immediately after
sorting, cells were imaged under fluorescence light or incubated at 30C for
fitness assays, either in an Infinite M200 microplate reader (Tecan) or in an
Image Xpress Microscope (Molecular Devices).
Automated Colony Growth Assays
S. cerevisiae cells grown in different conditions were diluted and attached to
a 96-well plate by Concanavalin-A-mediated cell adhesion. Imaging was
automatically performed every 60 min on an Image Xpress Microscope
(Molecular Devices). Colonies were identified in a bright field image in two228 Cell Reports 16, 222–231, June 28, 2016steps. First, we identified clusters of pixels where
the bright pixels of the image were juxtaposed
with the dark pixels (that occur in the case of
yeast cells). To assign the bright and dark pixels
in each image, mean and SD of pixel intensities
were calculated. Bright pixels had intensities
greater than mean + 2.2 3 SD, whereas dark
ones corresponded to intensities lower than
mean  2.2 3 SD. In addition, Sobel edge detec-
tion (Sobel, 1968) was used to identify sharp
changes in intensity, which happen in the case
of yeast cells at the cell boundary. After classifi-
cation of all the clusters in an image, the centroid
position for each cluster was calculated. In the
second step, the centroids of the clusters in
the series of images taken over time were
computationally aligned. Clusters that showedat least doubling in area over the entire period of observation were consid-
ered in our analysis. Growth rate was calculated as change in the natural
log-transformed area over time. To identify fluorescent cytoplasmic assem-
blies in each image, mean fluorescence intensity and SD of all pixels were
calculated. Only pixels with intensities greater than mean + 3 3 SD were
considered as cytoplasmic assemblies. To avoid spurious inference on
dissolution of foci, only the clusters with observations of foci in at least
five time points and observations for dissolved protein on at least five
time points were considered in our analysis.
FRAP
S. cerevisiae cells grown until exponential phase in inducing conditions were
immobilized to an 8-well cover slide by Concanavalin-A-mediated cell adhe-
sion. Cells were then imaged under a Confocal TCS SP5 microscope (Leica)
where bleaching was achieved with 488 Laser Power at 50% for three frames
(1.3 s/frame) while recovery was recorded for 50 frames. The curves were then
fitted to a single exponential, following normalization, with the EasyFrap pack-
age (Rapsomaniki et al., 2012).
Immunochemistry
Samples were run in precast NOVEX NuPAGE 4%–12% gels in denaturing
conditions. The Invitrogen iBlot system was used to transfer proteins to
PVDF membranes. After blocking, membranes were incubated overnight at
4Cwith anti-GFP rabbit antibody (Santa Cruz sc-8334), anti-HA 3F10 rat anti-
body (Roche 11867431001), or anti-PGKD1 mouse antibody (Novex 459250)
diluted 1:1,000, 1:4,000, and 1:10,000, respectively. Secondary incubation
with anti-Protein G HRP conjugated (Millipore 18-161) at 1:10,000 was per-
formed at room temperature (RT) during 1 hr. ImageJ 1.49v software was
used to quantify protein bands. Dot blots were performed by microfiltration
where lysate samples passed through a 0.1 nm nitrocellulose membrane.
The membrane was then blocked and incubated with the anti-amyloid fibrils
OC antibody (Millipore AB2286) in 1:1,000 dilution.
Figure 7. Mip6p Cytoplasmic Foci Are Causative of Fitness
Impairment
(A) Cellular localization of Mip6p when overexpressed in different genetic
deletion backgrounds.
(B) Growth rate of strains overexpressing Mip6p in different genetic deletion
backgrounds. The Gal1 promoter is integrated at the endogenousMip6 locus.
Error bars represent SD of three independent replicates.
See also Figure S6.
Figure 6. Translation Rates Are Reduced in Cells Overexpressing
Mip6p
S35Met incorporation over time as measured in WT cells and in cells
overexpressing Mip6p, where cytoplasmic foci are evident and fitness is
impaired.Cycloheximide Treatment
Strains were grown until exponential phase in inducing conditions fol-
lowed by 1 hr incubation with 0.25% CHX before observation under the
microscope.
Translation Efficiency
Ten hours after induction with galactose, cells were incubated with 35S-methi-
onine (NEG709A001MC) for 5, 15, or 30 min. A standard ethanol/glass beads
protocol was used for whole protein extraction. Samples were loaded in a
denaturing acrylamide gel and blue colloidal was applied for visualizing the
total amount of loaded protein. A CL-Xposure Film was then employed to
detect radioactivity on a Typhoon Trio imager (GE Healthcare). Quantification
was performed using ImageQuant (GE Healthcare), followed by normalization
of the 35S signal to Colloidal Blue intensity.
The catGRANULE Algorithm
The tendency to assemble into foci is predicted using RNA binding and struc-
tural disordered propensities identified through a computational screening
(Table S3) (Klus et al., 2014), as well as amino acid patterns and the poly-
peptide length. We selected the combination of RNA-binding and structural
disordered predictors that best discriminates proteins with potential for
foci formation (120 genes ‘‘Granule Forming’’ fromMitchell et al. [2013]) (Table
S1) from the proteome (4,145 proteins excluding 770 genes from Sopko et al.
[2006] and 777 genes from Makanae et al. [2013]). To cross-validate our pre-
dictions, we used an independent set of genes identified through a QuickGO
search with query ‘‘granules’’ (16 proteins in common with ‘‘granule forming’’
and 64 ‘‘granule related’’; Table S1).
The granule propensity (g) of an amino acid s at position i is defined as
giðsÞ= aR$RiðsÞ+ aD$DiðsÞ+ aP$PiðsÞ; (Equation 1)
where Ri = (RC,RN)i are the amino acid propensities of classical RC and
recently discovered RN RNA-binding proteins (Castello et al., 2012), Di =
(DC,DB)i estimates the structural disorder content based on coil DC
and bending DB features (Dele´age and Roux, 1987; Isogai et al., 1980),
Pi = (PRG,PFG)i takes into account arginine-glycine and phenylalanine-
glycine content (Kato et al., 2012; Thandapani et al., 2013) (Table S4).
Each property is calculated on a heptapeptide centered at position i in
the sequence.
The overall granule propensity is calculated asgranule propensity=
1
[
X[
i = 1
giðsÞ + a[ logð[Þ (Equation 2)
where [ is the sequence length.
The coefficients aR =

0:48
7:24

, aD =

0:26
11:54

, aP =

1:98
1:42

, and a[ = 0:25
were determined using aMonte Carlo search. The granule propensity shown in
Figure 1C is Z-normalized (mean 0 and SD 1 on the yeast proteome).
The performances of the algorithm was assessed using a 5-fold cross-vali-
dation (area under the receiver operating characteristic (ROC) curve, AUC, of
0.86 for ‘‘granule forming’’ genes; Figure 1A) and on an additional set (AUC of
0.72 for ‘‘granule related’’ genes; Figure 1A). With respect to dosage-sensitiveCell Reports 16, 222–231, June 28, 2016 229
genes identified by Sopko et al. (2006) and Makanae et al. (2013), AUCs
are 0.65 and 0.69 (Figure 1B). Gene groups are discriminated even
when DNA-binding proteins are removed from original sets (Sopko et al.
[2006]: AUC = 0.64; Makanae et al. [2013]: AUC = 0.67). Elimination of
sequence length contribution from Equation 2 ða[ = 0Þ marginally reduces
overall performances (‘‘granule forming’’: AUC = 0.80; ‘‘granule related’’:
AUC = 0.70).
To visualize the granule propensity ~gi of each amino acid i we average gi(s)
on a sliding window of 50 amino acids and Z-normalize the score (mean 0 and
SD of 1 on the yeast proteome). The granule strength (Figure 4B) is calculated
using the fraction of amino acids with ~gi > 0:
granule strength=
P
frag
~gi wð~giÞP
fragwð~giÞ
(Equation 3)
where wðxÞ is the Heaviside function that is 1 if x > 0 and zero otherwise on the
fragment of interest (frag). In the case of full-length Mip6, the granule strength
of the entire sequence can be visualized in Figure S7B.
All protein sequences were retrieved from the UniProt database (Uniprot
Consortium, 2013). The catGRANULE algorithm is freely available at http://
service.tartaglialab.com/grant_submission/catGRANULE.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, and three
movies and can be found with this article online at http://dx.doi.org/10.1016/
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